| Kathryn Brooke Bartlett, DO | |
|
5950 University Ave Ste 105, West Des Moines, IA 50266-7756 | |
| (515) 875-9070 | |
| (515) 875-9071 |
| Full Name | Kathryn Brooke Bartlett |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 5950 University Ave Ste 105, West Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568990869 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
| Grinnell Regional Medical Center | Grinnell, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grinnell Regional Medical Center | 0446153662 | 53 |
| Central Iowa Hospital Corporation | 1052229275 | 159 |
| The Iowa Clinic Pc | 4082513742 | 273 |
News Archive
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 2 days ago
| Entity Name | The Iowa Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346233178 PECOS PAC ID: 4082513742 Enrollment ID: O20040102000222 |
News Archive
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 2 days ago
| Entity Name | Grinnell Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669420501 PECOS PAC ID: 0446153662 Enrollment ID: O20040127001219 |
News Archive
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 2 days ago
| Entity Name | Central Iowa Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104879576 PECOS PAC ID: 1052229275 Enrollment ID: O20040128001102 |
News Archive
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Brooke Bartlett, DO Po Box 424, Des Moines, IA 50302-0424 Ph: (515) 875-9255 | Kathryn Brooke Bartlett, DO 5950 University Ave Ste 105, West Des Moines, IA 50266-7756 Ph: (515) 875-9070 |
News Archive
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 2 days ago
Jeffrey Charles Schoon, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6010 Mills Civic Pkwy, Suite 200, West Des Moines, IA 50266 Phone: 515-224-9666 Fax: 515-224-5913 | |
Stephanie A Ezebuiro, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 73rd St Ste 20, West Des Moines, IA 50265 Phone: 515-223-6794 | |
Dr. Stephanie M Stitt Cox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 220, West Des Moines, IA 50266 Phone: 515-875-9410 Fax: 515-875-9412 | |
Robert Kruse, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 1055 Jordan Creek Pkwy Ste 100, West Des Moines, IA 50266 Phone: 515-358-5950 Fax: 515-358-5951 | |
Dr. Melissa J Thompson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 220, West Des Moines, IA 50266 Phone: 515-875-9410 Fax: 515-875-9412 | |
Meredith Swenson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6010 Mills Civic Pkwy, West Des Moines, IA 50266 Phone: 515-224-9666 | |
Jennifer L Fejfar, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6000 University Ave, Suite 101, West Des Moines, IA 50266 Phone: 515-241-2600 Fax: 515-241-2032 |